Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 1473 - 1488 of 91813 for .

Showing results 1473 - 1488 of 91813 for .

Terms of Use | Covance
Covance Terms of Use policy.
Upcoming Covance Events
Keep up-to-date with the latest thinking about the science and business of drug development. View our list of upcoming events.
Sitemap | Covance
View Covance's sitemap to find content on our site.
Contract Research Organization (CRO) | Clinical Trials | Covance
Covance, a global contract research organization and drug development services company, has helped bring 49 of the top 50 best-selling drugs to market.
Beliefs in Action
Over the past 30 years, we’ve established and maintained a corporate culture that makes animal welfare a top priority. From our commitment to the 3Rs to our careful adherence to government regulations, we strive every day to make sure we treat our research animals humanely and with respect.
Our Commitment to Animal Welfare
Covance is committed to ensuring the welfare of animals used in research.  Animal research is critical to developing new, safe and effective medicines that save the lives of people and animals. At Covance, we treat the animals we use in biomedical research humanely and with compassion and respect. We also adhere to strict standards of care and ethical principles in providing for their welfare.
About Covance
Covance Inc., a global contract research organization (CRO), is the world’s most comprehensive drug development company.
Impact on Results
Like many of you who visit this website, we care deeply about animals and strive to treat them humanely and respectfully ­– always.
Code of Respect
Animal welfare is of primary concern for all of us at Covance, from our CEO to our employees at facilities around the world.
Corporate Responsibility | Covance
At Covance, the steps we take to create a cleaner, safer, healthier planet can be traced back to our corporate values.
Covance Executive Leadership
Our Executive Leadership team is committed to delivering innovative solutions that transform scientific possibilities into realities.
Dimitris K. Agrafiotis, PhD, FRSC
Dr. Dimitris K. Agrafiotis, PhD, FRSC Vice President and Chief Data Officer, Covance
Herman E. Scholtz, MD | Covance
Herman E. Scholtz, MD
Why Animal Research
Ensuring the safety of new medicines.
Chris Gegelys | Covance
Chris Gegelys, General Counsel
Jonathan Zung, PhD | Covance
Jonathan Zung, PhD, Group President, Clinical Development & Commercialization Services